Nan Zhang
The Wistar Institute(US)Qingdao University(CN)Ministry of Education of the People's Republic of China(CN)Liaoning Normal University(CN)Shandong University(CN)Harbin Medical University(CN)Chongqing University(CN)Shanxi Medical University(CN)Xuzhou Medical College(CN)Capital Medical University(CN)Jilin University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Sichuan University(CN)Peking Union Medical College Hospital(CN)Chinese PLA General Hospital(CN)AbbVie (United States)(US)Tianjin Synthetic Material Research Institute (China)(CN)West China Hospital of Sichuan University(CN)Henan Academy of Sciences(CN)Peking University Cancer Hospital(CN)Shaanxi Xueqian Normal University(CN)Chinese Institute for Brain Research(CN)Affiliated Hospital of Qingdao University(CN)Beijing Anzhen Hospital(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)Fuzhou Pulmonary Hospital of Fujian(CN)Mayo Clinic in Arizona(US)First Hospital of Jilin University(CN)First Hospital of Shanxi Medical University(CN)Beijing Aerospace General Hospital(CN)Second Affiliated Hospital of Harbin Medical University(CN)Second Hospital of Tianjin Medical University(CN)Key Laboratory of Nuclear Radiation and Nuclear Energy Technology(CN)Cellular Therapeutics (United Kingdom)(GB)Ministry of Education(ET)Sanya University(CN)Ministry of Agriculture and Rural Affairs(CN)Shenzhen Technology University(CN)Chongqing Cancer Hospital(CN)Baotou Medical College(CN)Shandong First Medical University(CN)First Hospital of Xi'an(CN)State Key Laboratory of Crystal MaterialsPing An (China)Chinese Academy of Fishery Sciences(CN)Huazhong University of Science and Technology(CN)Tianjin Medical University(CN)Yangzhou University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, Immune cells in cancer
Most-Cited Works
- → Glioma targeted therapy: insight into future of molecular approaches(2022)696 cited
- → Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer(2021)502 cited
- → Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials(2023)360 cited
- → Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer(2021)334 cited
- → A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer(2014)312 cited
- → PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer